Skip to content

Glycine reuptake inhibitor for the treatment of drug and alcohol dependence

Glycine reuptake inhibitor for the treatment of drug and alcohol dependence

Glycine reuptake inhibitors for treating drug and alcohol dependence. European patent EP1841418B1

The invention relates to a method of treating or preventing drug addiction, particularly alcoholism, in humans, comprising administering to a subject in need thereof an effective amount of a Gly-T1 inhibitor, particularly N-methyl-N-[[(1R,2S)-1,2,3,4-tetrahydro-6-methoxy-1-phenyl-2-naphthalenyl]methylglycine or a pharmaceutically acceptable salt thereof.


Glycine reuptake inhibitors for treating drug and alcohol dependence.

Powered by BetterDocs

This site is still under development. Feel free to look around and don't hesitate to give us feedback, you'll find a form at the end of each page.

Nevertheless, we activate a few cookies, and these cookies could change due to the fact. that it's a development-site.


Bye bye booze needs cookies, too. However, we try only to activate as few as possible technically necessary cookies so that your visit to this site cannot be tracked as far as possible by third parties.

 

However, we do need a few - e.g. to display this legal notice or to care for that you do not have to log in again for each page or see this popup again for each page.

 

As soon as you click on an external link or video, however, cookies may be set by the operators of these sites, which we cannot influence. Learn more on our privacy page.